Sumitomo Dainippon Pharma Co Ltd - Total Other Income Expense Net

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Other-Income-Expense-Net" stands at 62.50 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2022.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 57.59 Billion JPY for the item "Total Other Income Expense Net" represents an increase of 808.74 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 57.59 Billion JPY for the item "Total Other Income Expense Net" represents an increase of 229.36 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 62.50 Billion JPY for the item "Total Other Income Expense Net" represents an increase of 257.78 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 86.00 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 86.00 Billion Japanese Yens.
The 3 year change is -8.48 Billion Japanese Yens.
The 5 year change is 62.99 Billion Japanese Yens.
The 10 year change is 55.55 Billion Japanese Yens.

The Serie's long term average value is 5.51 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 56.99 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +102.11 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is -8.48 Billion.